Protective effect of caffeic acid phenethyl ester on cyclosporine A-induced nephrotoxicity in rats

Renal Failure

Volumn 31, Issue 9, 2009, Pages 843-847

  Gökçe, Ahmet ^a   Oktar, Süleyman ^a   Yönden, Zafer ^a   Aydin, Mehmet ^a   Ilhan, Selçuk ^b   Özkan, Orhan Veli ^a   Davarci, Mürsel ^a   Yalçinkaya, Fatih Rüştü ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Caffeic acid phenethyl ester; Catalase; Cyclosporine A; Malondialdehyde; Nephrotoxicity

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; CATALASE; CREATININE; CYCLOSPORIN A; MALONALDEHYDE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; LIPID PEROXIDATION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; CAFFEIC ACIDS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; RATS; RATS, WISTAR;

EID: 71049131591     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903137517     Document Type: Article

References (26)

1. Graeb C, Arbogast H, Guba M, Jauch KW, Land W. Cyclosporine: 20 years of experience at the University of Munich. Transplant Proc. 2004;36:125S-129S.
2. Duru M, Nacar A, Yonden Z, Kuvandik G, Helvaci MR, Koc A, et al. Protective effects of N-acetylcysteine on cyclosporine-A-induced nephrotoxicity. Ren Fail. 2008;30:453-459.
3. Nacar A, Kiyici H, Ogus E, Zagyapan R, Demirhan B, Ozdemir H, et al. Ultrastructural examination of glomerular and tubular changes in renal allografts with cyclosporine toxicity. Ren Fail. 2006;28:543-547.
4. Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol. 2003;23:465-476.
5. Adeagbo AS, Patel D, Iddrissu A, et al. NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptor-mediated contractions of rat aorta: Role of endothelium. Eur J Pharmacol. 2003;458:145-154.
6. Tariq M, Morais C, Sobki S, Al Sulaiman M, Al Khader A. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant. 1999;14:923-929.
7. Tseng TH, Lee YJ. Evaluation of natural and synthetic compounds from East Asiatic folk medicinal plants on the mediation of cancer. Anticancer Agents Med Chem. 2006;6:347-365.
8. Okutan H, Ozcelik N, Yilmaz HR, Uz E. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem. 2005;38:191-196.
9. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett. 1993;329:21-24.
10. Ilhan A, Koltuksuz U, Ozen S, Uz E, Ciralik H, Akyol O. The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur J Cardiothorac Surg. 1999;16:458-463.
11. Fadillioglu E, Oztas E, Erdogan H, et al. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol. 2004;24:47-52. (Pubitemid 38181541)
12. Iraz M, Ozerol E, Gulec M, Tasdemir S, Idiz N, Fadillioglu E, et al. Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochem Funct. 2006;24:357-361.
13. Rezzani R, Giugno L, Buffoli B, Bonomini F, Bianchi R. The protective effect of caffeic acid phenethyl ester against cyclosporine A-induced cardiotoxicity in rats. Toxicology. 2005;212:155-164.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
15. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407-421.
16. Wei H, Frenkel K. In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res. 1991; 51:4443-4449.
17. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497-500.
18. Aebi H. Methods of enzymatic analysis. Academic Press, New York, 1974.
19. Josephine A, Veena CK, Amudha G, Preetha SP, Varalakshmi P. Evaluating the effect of sulphated polysaccharides on cyclosporine a induced oxidative renal injury. Mol Cell Biochem. 2006;287:101-108.
20. Parra T, de Arriba G, Conejo JR, et al. Cyclosporine increases local glomerular synthesis of reactive oxygen species in rats: Effect of vitamin E on cyclosporine nephrotoxicity. Transplantation. 1998;66:1325-1329.
21. Heinecke JW, Li W, Francis GA, Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest. 1993;91:2866-2872.
22. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005;25: 1102-1111.
23. Zal F, Mostafavi-Pour Z, Vessal M. Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A-induced nephrotoxicity in male rats. Clin Exp Pharmacol Physiol. 2007;34:720-724.
24. Belboul A, Lofgren C, Storm C, Jungbeck M. Heparincoated circuits reduce occult myocardial damage during CPB: A randomized, single blind clinical trial. Eur J Cardiothorac Surg. 2000;17:580-586.
25. Pahlavani MA, Mele JF, Richardson A. Effect of overexpression of human Cu/Zn-SOD on activation-induced lymphocyte proliferation and apoptosis. Free Radic Biol Med. 2001;30:1319-1327.
26. Nishiyama A, Kobori H, Fukui T, et al. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension. 2003;42:754-760.